Arthur M. Cohen & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$8.72M |
| 2 |
DexCom
DXCM
|
+$1.56M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.12M |
| 4 |
Tesla
TSLA
|
+$929K |
| 5 |
Illumina
ILMN
|
+$761K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$29.1M |
| 2 |
Cboe Global Markets
CBOE
|
+$4.29M |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$3.05M |
| 4 |
Teladoc Health
TDOC
|
+$2.7M |
| 5 |
Aon
AON
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.48% |
| 2 | Technology | 18.31% |
| 3 | Financials | 15.14% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Communication Services | 8.19% |
Similar funds
Arthur M. Cohen & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Arthur M. Cohen & Associates held 147 positions worth $493M, down 4.5% from $516M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Arthur M. Cohen & Associates withdrew a net $34.3M in Q3 2021, closing 11 positions and reducing 37 holdings. Its most notable exit was Teladoc Health, an estimated $2.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Arthur M. Cohen & Associates opened a new position in DexCom worth $1.69M.
- Arthur M. Cohen & Associates's largest Q3 2021 buy was DexCom: 12,384 shares worth $1.69M.
- Arthur M. Cohen & Associates added most to Invesco QQQ Trust in Q3 2021, an estimated $8.72M increase.
- Arthur M. Cohen & Associates's biggest Q3 2021 reduction was AbbVie, cutting an estimated $29.1M.
- Arthur M. Cohen & Associates fully exited Teladoc Health in Q3 2021, selling an estimated $2.7M.
- Arthur M. Cohen & Associates's ten largest holdings make up 57% of its $493M portfolio in Q3 2021.
- Arthur M. Cohen & Associates opened 5 new positions and closed 11 in Q3 2021.
- Arthur M. Cohen & Associates's portfolio value fell 4.5% quarter-over-quarter to $493M.
Based on Arthur M. Cohen & Associates's 13F filing for Q3 2021, filed 8 Oct 2021.